Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D)

AIMS: Sodium glucose co‐transporter 2 inhibitors (SGLT2i) are indicated for treatment of type 2 diabetes mellitus (T2DM); some SGLT2i have reported cardiovascular benefit, and some have reported risk of below‐knee lower extremity (BKLE) amputation. This study examined the real‐world comparative effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Patrick B., Buse, John B., Schuemie, Martijn J., DeFalco, Frank, Yuan, Zhong, Stang, Paul E., Berlin, Jesse A., Rosenthal, Norman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220807/
https://www.ncbi.nlm.nih.gov/pubmed/29938883
http://dx.doi.org/10.1111/dom.13424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220807/
https://www.ncbi.nlm.nih.gov/pubmed/29938883
http://dx.doi.org/10.1111/dom.13424

Ejemplares similares